| For: | Neumann-Haefelin C, Spangenberg HC, Blum HE, Thimme R. Host and viral factors contributing to CD8+ T cell failure in hepatitis C virus infection. World J Gastroenterol 2007; 13(36): 4839-4847 [PMID: 17828815 DOI: 10.3748/wjg.v13.i36.4839] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i36/4839.htm |
| Number | Citing Articles |
| 1 |
Aybike Birerdinc, Arian Afendy, Maria Stepanova, Issah Younossi, Ancha Baranova, Zobair M. Younossi. Gene expression profiles associated with depression in patients with chronic hepatitis C (CH‐C). Brain and Behavior 2012; 2(5) doi: 10.1002/brb3.72
|
| 2 |
Polyxeni P. Doumba, Elisavet Serti, Maria Boutsikou, Manousos M. Konstadoulakis, Urania Georgopoulou, John Koskinas. Phenotypic and functional alterations of primary human PBMCs induced by HCV non-enveloped capsid-like particles uptake. Cellular and Molecular Life Sciences 2013; 70(18) doi: 10.1007/s00018-013-1344-y
|
| 3 |
Zobair M. Younossi, Ancha Baranova, Arian Afendy, Rochelle Collantes, Maria Stepanova, Ganiraju Manyam, Anita Bakshi, Christopher L. Sigua, Joanne P. Chan, Ayuko A. Iverson, Christopher D. Santini, Sheng‐Yung P. Chang. Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon‐alfa and ribavirin†. Hepatology 2009; 49(3) doi: 10.1002/hep.22729
|
| 4 |
Jessica Spahn, Robert H. Pierce, Ian N. Crispe. Ineffective CD8+ T-Cell Immunity to Adeno-Associated Virus Can Result in Prolonged Liver Injury and Fibrogenesis. The American Journal of Pathology 2011; 179(5) doi: 10.1016/j.ajpath.2011.08.004
|
| 5 |
Cheng J. Ma, Jun P. Ren, Guang Y. Li, Xiao Y. Wu, Dirk G. Brockstedt, Peter Lauer, Jonathan P. Moorman, Zhi Q. Yao, Naglaa H. Shoukry. Enhanced Virus-Specific CD8+ T Cell Responses by Listeria monocytogenes-Infected Dendritic Cells in the Context of Tim-3 Blockade. PLoS ONE 2014; 9(1) doi: 10.1371/journal.pone.0087821
|
| 6 |
Silvana Gaudieri, Andri Rauch, Katja Pfafferott, Eleanor Barnes, Wendy Cheng, Geoff McCaughan, Nick Shackel, Gary P. Jeffrey, Lindsay Mollison, Ross Baker, Hansjakob Furrer, Huldrych F. Günthard, Elizabeth Freitas, Isla Humphreys, Paul Klenerman, Simon Mallal, Ian James, Stuart Roberts, David Nolan, Michaela Lucas. Hepatitis C virus drug resistance and immune-driven adaptations: Relevance to new antiviral therapy #. Hepatology 2009; 49(4) doi: 10.1002/hep.22773
|
| 7 |
Ajax M. Atta, Isabela S. Oliveira, Gabriel M. Sousa, Raymundo Paraná, Maria L. Sousa Atta. Serum cytokine profile in hepatitis C virus carriers presenting cryoglobulinaemia and non-organ-specific autoantibodies. Microbial Pathogenesis 2010; 48(2) doi: 10.1016/j.micpath.2009.12.002
|
| 8 |
|
| 9 |
M. Sidorkiewicz, M. Brocka, M. Bronis, M. Grek, B. Jozwiak, A. Piekarska, J. Bartkowiak. The altered expression of α1 and β3 subunits of the gamma-aminobutyric acid A receptor is related to the hepatitis C virus infection. European Journal of Clinical Microbiology & Infectious Diseases 2012; 31(7) doi: 10.1007/s10096-011-1475-8
|
| 10 |
Julia Schmidt, Hubert E Blum, Robert Thimme. T-cell responses in hepatitis B and C virus infection: similarities and differences. Emerging Microbes & Infections 2013; 2(1) doi: 10.1038/emi.2013.14
|
| 11 |
Maria Nikolova, Jean-Daniel Lelievre, Matthieu Carriere, Armand Bensussan, Yves Lévy. Regulatory T cells differentially modulate the maturation and apoptosis of human CD8+ T-cell subsets. Blood 2009; 113(19) doi: 10.1182/blood-2008-04-151407
|
| 12 |
A. Birerdinc, A. Afendy, M. Stepanova, I. Younossi, G. Manyam, A. Baranova, Z. M. Younossi. Functional pathway analysis of genes associated with response to treatment for chronic hepatitis C. Journal of Viral Hepatitis 2010; 17(10) doi: 10.1111/j.1365-2893.2009.01235.x
|
| 13 |
Jason Grebely, Maria Prins, Margaret Hellard, Andrea L Cox, William O Osburn, Georg Lauer, Kimberly Page, Andrew R Lloyd, Gregory J Dore. Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine. The Lancet Infectious Diseases 2012; 12(5) doi: 10.1016/S1473-3099(12)70010-5
|
| 14 |
Ian Gaël Rodrigue-Gervais, Hawley Rigsby, Loubna Jouan, Dominike Sauvé, Rafick-Pierre Sékaly, Bernard Willems, Daniel Lamarre. Dendritic Cell Inhibition Is Connected to Exhaustion of CD8+ T Cell Polyfunctionality during Chronic Hepatitis C Virus Infection. The Journal of Immunology 2010; 184(6) doi: 10.4049/jimmunol.0902522
|
| 15 |
Cordelia Manickam, Premeela Rajakumar, Lynn Wachtman, Joshua A. Kramer, Amanda J. Martinot, Valerie Varner, Luis D. Giavedoni, R. Keith Reeves, R. M. Sandri-Goldin. Acute Liver Damage Associated with Innate Immune Activation in a Small Nonhuman Primate Model of Hepacivirus Infection. Journal of Virology 2016; 90(20) doi: 10.1128/JVI.01051-16
|
| 16 |
Leila Y. Chihab, Rebecca Kuan, Elizabeth J. Phillips, Simon A. Mallal, Virginie Rozot, Mark M. Davis, Thomas J. Scriba, Alessandro Sette, Bjoern Peters, Cecilia S. Lindestam Arlehamn. Expression of specific HLA class II alleles is associated with an increased risk for active tuberculosis and a distinct gene expression profile. HLA 2023; 101(2) doi: 10.1111/tan.14880
|
| 17 |
Samina Baig, Assel Berikkara, Ramsha Khalid, Syed A. Subhan, Tanveer Abbas, Syed Hani Abidi. In silico analysis of the effect of HCV genotype-specific polymorphisms in Core, NS3, NS5A, and NS5B proteins on T-cell epitope processing and presentation. Frontiers in Microbiology 2025; 15 doi: 10.3389/fmicb.2024.1498069
|
| 18 |
Shallu Tomer, Sunil K. Arora. A juggernaut of innate & adaptive immune cells in chronic hepatitis C. Indian Journal of Medical Research 2020; 151(4) doi: 10.4103/ijmr.IJMR_1387_17
|
| 19 |
Mohammed Mohammed El-Banna, Fawzeya Hassan Abo Aly, Manal Ahmad Shams Eldein El-Telbany, Samar Abdallah Mohamed Salem, Sonia Ahmad Elgaaly, Nehal Abd El-Fattah El-Fawy. Hepatitis C with and without dermatological manifestations. Journal of the Egyptian Womenʼs Dermatologic Society 2011; 8(1) doi: 10.1097/01.EWX.0000392822.59573.b5
|
| 20 |
Silvia Coelho-Borges, Hugo Cheinquer, Fernando Herz Wolff, Nelson Cheinquer, Luciano Krug, Patricia Ashton-Prolla. Effect of HFE gene polymorphism on sustained virological response in patients with chronic hepatitis C and elevated serum ferritin. Arquivos de Gastroenterologia 2012; 49(1) doi: 10.1590/S0004-28032012000100003
|
| 21 |
Isabela S. Oliveira, Lucas P. Carvalho, Maria Isabel Schinoni, Raymundo Paraná, Ajax M. Atta, Maria Luiza B. Sousa Atta. Peripheral lymphocyte subsets in chronic hepatitis C: Effects of 12 weeks of antiviral treatment with interferon-alpha plus ribavirin. Microbial Pathogenesis 2016; 91 doi: 10.1016/j.micpath.2015.12.007
|
| 22 |
Grenda Leite Pereira, Andréa Monteiro Tarragô, Walter Luiz Lima Neves, Pedro Vieira da Silva Neto, Priscila Sarmento de Souza, Juliana dos Santos Affonso, Keyla Santos de Sousa, Jéssica Albuquerque da Silva, Allyson Guimarães Costa, Flamir da Silva Victoria, Marilu Barbieri Victoria, Adriana Malheiro. Immunological Dynamics Associated with Direct-Acting Antiviral Therapies in Naive and Experimented HCV Chronic-Infected Patients. Mediators of Inflammation 2019; 2019 doi: 10.1155/2019/4738237
|
| 23 |
Enass A. Abdel-hameed, Susan D. Rouster, Hong Ji, Ashley Ulm, Helal F. Hetta, Nadeem Anwar, Kenneth E. Sherman, Mohamed Tarek M. Shata. Evaluating the Role of Cellular Immune Responses in the Emergence of HCV NS3 Resistance Mutations During Protease Inhibitor Therapy. Viral Immunology 2016; 29(4) doi: 10.1089/vim.2015.0093
|
| 24 |
Carlo Patrono, John Burn, Paola Patrignani, Ruth E. Langley. Platelet activation, aspirin, and cancer: From basic science to clinical trials. Pharmacological Reviews 2026; 78(1) doi: 10.1016/j.pharmr.2025.100109
|
| 25 |
Aybike Birerdinc, Zobair M Younossi. Emerging therapies for hepatitis C virus. Expert Opinion on Emerging Drugs 2010; 15(4) doi: 10.1517/14728214.2010.502527
|
| 26 |
L. Alvarez‐Lajonchere, N. H. Shoukry, B. Grá, Y. Amador‐Cañizares, F. Helle, N. Bédard, I. Guerra, C. Drouin, J. Dubuisson, E. E. González‐Horta, G. Martínez, J. Marante, Z. Cinza, M. Castellanos, S. Dueñas‐Carrera. Immunogenicity of CIGB‐230, a therapeutic DNA vaccine preparation, in HCV‐chronically infected individuals in a Phase I clinical trial. Journal of Viral Hepatitis 2009; 16(3) doi: 10.1111/j.1365-2893.2008.01058.x
|
| 27 |
Julia Schmidt, Robert Thimme, Christoph Neumann-Haefelin. Host Genetics in Immune-Mediated Hepatitis C Virus Clearance. Biomarkers in Medicine 2011; 5(2) doi: 10.2217/bmm.11.19
|
| 28 |
Paul Shapshak, Charurut Somboonwit, Lydia N. Drumright, Simon D.W. Frost, Deborah Commins, Timothy L. Tellinghuisen, William K. Scott, Robert Duncan, Clyde McCoy, J. Bryan Page, Brian Giunta, Francisco Fernandez, Elyse Singer, Andrew Levine, Alireza Minagar, Oluwadayo Oluwadara, Taiwo Kotila, Francesco Chiappelli, John T. Sinnott. Molecular and Contextual Markers of Hepatitis C Virus and Drug Abuse. Molecular Diagnosis & Therapy 2009; 13(3) doi: 10.1007/BF03256323
|
| 29 |
Zobair M. Younossi, Dolores Limongi, Maria Stepanova, Mariaelena Pierobon, Arian Afendy, Rohini Mehta, Ancha Baranova, Lance. Liotta, Emanuel. Petricoin. Protein Pathway Activation Associated with Sustained Virologic Response in Patients with Chronic Hepatitis C Treated with Pegylated Interferon (PEG-IFN) and Ribavirin (RBV). Journal of Proteome Research 2011; 10(2) doi: 10.1021/pr100923u
|
| 30 |
Silvia Guglietta, Anna Rosa Garbuglia, Leonidas Salichos, Lionello Ruggeri, Antonella Folgori, Maria Paola Perrone, Cristina Camperio, Vincenzo Mellace, Giuseppe Maio, Patrizia Maio, Maria Rosaria Capobianchi, Enea Spada, Nicola Gargano, Cristiano Scottà, Enza Piccolella, Paola Del Porto. Impact of viral selected mutations on T cell mediated immunity in chronically evolving and self limiting acute HCV infection. Virology 2009; 386(2) doi: 10.1016/j.virol.2009.01.020
|
| 31 |
Michael A. Nalesnik, Tatsuya Kanto. Natural Killer Cells. 2010; doi: 10.1016/B978-0-12-370454-2.00044-2
|
| 32 |
Emma C. Thomson, Jennifer A. Smith, Paul Klenerman. The natural history of early hepatitis C virus evolution; lessons from a global outbreak in human immunodeficiency virus-1-infected individuals. Journal of General Virology 2011; 92(10) doi: 10.1099/vir.0.033910-0
|
| 33 |
Judith D. Easterbrook, Sabra L. Klein. Seoul virus enhances regulatory and reduces proinflammatory responses in male Norway rats. Journal of Medical Virology 2008; 80(7) doi: 10.1002/jmv.21213
|
| 34 |
Hirofumi Akari, Yuki Iwasaki, Tomoyuki Yoshida, Sayuki Iijima. Non‐human primate surrogate model of hepatitis C virus infection. Microbiology and Immunology 2009; 53(1) doi: 10.1111/j.1348-0421.2008.00087.x
|
| 35 |
Ling Zhao, Babal K. Jha, Ashley Wu, Ruth Elliott, John Ziebuhr, Alexander E. Gorbalenya, Robert H. Silverman, Susan R. Weiss. Antagonism of the Interferon-Induced OAS-RNase L Pathway by Murine Coronavirus ns2 Protein Is Required for Virus Replication and Liver Pathology. Cell Host & Microbe 2012; 11(6) doi: 10.1016/j.chom.2012.04.011
|
| 36 |
Rowena A. Bull, Preston Leung, Silvana Gaudieri, Pooja Deshpande, Barbara Cameron, Melanie Walker, Abha Chopra, Andrew R. Lloyd, Fabio Luciani, J.-H. J. Ou.
Transmitted/Founder Viruses Rapidly Escape from CD8
+
T Cell Responses in Acute Hepatitis C Virus Infection
. Journal of Virology 2015; 89(10) doi: 10.1128/JVI.03717-14
|
| 37 |
Justyna Kaźmierczak, Kamila Caraballo Cortes, Iwona Bukowska-Ośko, Marek Radkowski. Virus-Specific Cellular Response in Hepatitis C Virus Infection. Archivum Immunologiae et Therapiae Experimentalis 2016; 64(2) doi: 10.1007/s00005-015-0364-8
|
| 38 |
Virginie Pichard, Mickaël Guilbaud, Marie Devaux, Nicolas Jaulin, Malo Journou, Magalie Cospolite, Alexandra Garcia, Nicolas Ferry, Sophie Michalak-provost, Gwladys Gernoux, Oumeya Adjali. Incomplete elimination of viral genomes is associated with chronic inflammation in nonhuman primate livers after AAV-mediated gene transfer. Gene Therapy 2025; 32(3) doi: 10.1038/s41434-025-00514-z
|
| 39 |
Bertram Bengsch, Robert Thimme, Hubert E. Blum. Role of Host Genetic Factors in the Outcome of Hepatitis C Virus Infection. Viruses 2009; 1(2) doi: 10.3390/v1020104
|
| 40 |
Konstantinos Tsiakos, Niki Gavrielatou, Ioannis Vathiotis, Loukas Chatzis, Stamatios Chatzis, Garyfallia Poulakou, Elias Kotteas, Nikolaos Syrigos. Programmed Cell Death Protein 1 Axis Inhibition in Viral Infections: Clinical Data and Therapeutic Opportunities. Vaccines 2022; 10(10) doi: 10.3390/vaccines10101673
|
| 41 |
Zobair M Younossi, Aybike Birerdinc, Mike Estep, Maria Stepanova, Arian Afendy, Ancha Baranova. The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin. Journal of Translational Medicine 2012; 10(1) doi: 10.1186/1479-5876-10-25
|